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peritoneal exudate eosinophils harvested from polymyxin B-
treated guinea pigs are similar to those harvested from un-
treated animals [9]. Certain differences are noteworthy. Firstly, 
guinea pig eosinophils had a lower resting production of hydro-
gen peroxide, which is not due to decreased oxidative metabo-
lism since stimulated guinea pig eosinophils had more active 
oxidative metabolism. Increased resting hydrogen peroxide 
release by human eosinophils could represent modification of 
peripheral blood eosinophils by circulating factors [17]. Alter-
natively, the site of hydrogen peroxide release in human eosin-
ophils may be more accessible to measurement by our extra-
cellular assay system. Stimulated guinea pig eosinophils appear 
to release more hydrogen peroxide than human eosinophils; 
this may represent more active oxidative metabolism or a more 
accessible site of production. The greater amount of hydrogen 
peroxide release following stimulation by preopsonized zymosan 
may reflect differences in the numbers of C3b receptors present 
on human and guinea pig eosinophils. 
Previous studies of eosinophils have focused on quantitative 
differences between eosinophils and neutrophils [16-18]. Eosin-
ophils, usually obtained from hypereosinophilic patients, were 
more active than neutrophils [18-20]. Preliminary studies in 
om la boratory note few quantitative differences between eosin-
ophils and neutrophils. An important quantitative difference is 
that eosinophils do produce small amounts of hydrogen perox-
ide under resting conditions, whereas neutrophils have essen-
tially no detectable hydrogen per.oxide production. Eosinophils 
produce approximately 10-fold more hydrogen peroxide than 
activated peritoneal exudate macrophages, which have a rela-
tively low level of oxidative metabolism [14,20]; this difference 
is more than would be expected on the basis of laboratory 
variation. 
Differences in hydrogen peroxide release between eosinophils 
from normal persons and patients with hypereosinophilic syn-
drome were observed, consistent with our observations that 
metabolic heterogeniety exists among human eosinophils [12]. 
Unfortunately the small number of patients available for study 
make it difficul t to draw any conclusions. They do suggest that 
a worthwhile question is whether elevated hydrogen peroxide 
production might be responsible for enhanced parasite killing 
[17], especially in view of our observations that circulating 
factors can enhance oxidative metabolism of eosinophils [21]. 
The demonstration that large amounts of hydrogen peroxide 
can be elicited after appropriate stimuli and that small amounts 
are continuously secreted are further support for the hypothesis 
that eosinophils play an in1portant effector role in parasitic 
infection. 
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